DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 1.57% to $793.74 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.48% to 7,619.98 and Dow Jones Industrial Average falling 0.29% to 52,421.20.
The stock's rise snapped a six-day losing streak.
Regeneron Pharmaceuticals Inc. closed 7.63% below its 52-week high of $859.34, which the company reached on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 1.10% to $381.50, Moderna Inc. (MRNA) rose 1.89% to $146.69, and Gilead Sciences Inc. (GILD) rose 1.87% to $146.41.
Trading volume (582,948) remained 146,352 below its 50-day average volume of 729,300.
Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.